|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/7115 | |
| A61K 31/7125 | |||
| A61P 1/16 | |||
| A61P 31/20 |
| (11) | Number of the document | 2512491 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10824199.3 |
| Date of filing the European patent application | 2010-10-15 | |
| (97) | Date of publication of the European application | 2012-10-24 |
| (45) | Date of publication and mention of the grant of the patent | 2017-10-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/052911 |
| Date | 2010-10-15 |
| (87) | Number | WO 2011/047312 |
| Date | 2011-04-21 |
| (30) | Number | Date | Country code |
| 252380 P | 2009-10-16 | US |
| (72) |
HAMATAKE, Robert, US
|
| (73) |
Glaxo Group Limited,
980 Great West Road, Brentford, Middlesex TW8 9GS,
GB
|
| (54) | HBV ANTISENSE INHIBITORS |
| HBV ANTISENSE INHIBITORS |